The first day of World Immunisation Week (WIW) coincides with World Malaria Day and so for London School of Hygiene and Tropical Medicine's first WIW session of 2022, it will explore the issue of Malaria – where are the vaccines?
The webinar, chaired by Kevin Tetteh from LSHTM, will include a presentation by Faith Osier from International AIDS Vaccine Initiative on the developments in malaria vaccines from a general and historical perspective. We will then be joined by Alassane Dicko from the University of Science, Techniques and Technologies of Bamako, Mali, who will present the Phase IV implementation studies for the RTS,S vaccine.
- Kevin is an Associate Professor at LSHTM and sits on the steering committee for the Vaccine Centre. Kevin’s research focuses on the molecular genetics and characterisation of antigens associated with the merozoite stage of the malarial parasite Plasmodium falciparum as well as vaccine discovery and design.
- Professor Faith Osier is the Executive Director of the Human Immunology Laboratory (HIL). She is also a visiting Professor of Immunology at Oxford University and serves as the President of the International Union of Immunological Societies. Professor Osier’s expertise is in malaria research with the aim to “Make Malaria History”.
- Alassane Dicko is a Professor of Epidemiology and Public Health at the Malaria Research and Training Center (MRTC) of the University of Science Techniques and Technologies of the Bamako and a Senior Investigator at the Bruyère Research Institute in Ottawa. His research has focused on improving ways of preventing and treating malaria in areas where malaria transmission is highly seasonal, such as Mali. He has been a pioneer in the development of Seasonal Malaria Chemoprevention, a control measure now being deployed widely in many countries of the Sahel and sub-Sahel where malaria transmission is highly seasonal. His group at the MRTC is working with the LSHTM, the University of Oxford, and NIAID on several malaria vaccines including RTS, S, R21, and PfSPZ, and drugs to block malaria transmission.